FDA eyes second COVID-19 booster shot

Wall Street Journal

19 February 2022 - The agency has begun reviewing data that could lead to clearing a second booster dose of the Pfizer, Moderna vaccines in the fall.

U.S. health regulators are looking at potentially authorising a fourth dose of a COVID-19 vaccine in the fall, according to people familiar with the matter.

Read Wall Street Journal article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Regulation , Vaccine , COVID-19